Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Audit exposes flawed blood sampling for "digoxin levels".

C R Kumana1, Y M Chan, M Kou

  • 1Department of Medicine, University of Hong Kong, Queen Mary Hospital.

Therapeutic Drug Monitoring
|April 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Parental Anxiety in Differences of Sex Development and Hypospadias: A Psychosocial Characterization.

medRxiv : the preprint server for health sciences·2025
Same author

Towards a core outcome set for sarcopenia intervention studies: a scoping review identifying the most frequently reported outcomes across randomized controlled trials in sarcopenia.

European geriatric medicine·2025
Same author

[Establishment and validation of clinical prediction model for steroid-resistant nephrotic syndrome in children].

Zhonghua er ke za zhi = Chinese journal of pediatrics·2023
Same author

Genetic association of retroesophageal left brachiocephalic vein.

Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology·2019
Same author

Prenatal visualization of paraumbilical veins in fetus with intra-abdominal umbilical vein stricture and intrauterine growth restriction.

Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology·2019
Same author

Antibiotic Guidelines.

Journal of the Royal College of Physicians of London·2019
Same journal

Wide-Range Quantification of Belumosudil in Patients with Chronic Graft-Versus-Host Disease by High-Performance Liquid Chromatography.

Therapeutic drug monitoring·2026
Same journal

Deltamethrin Placental Transfer and Seasonal Pyrethroid Exposure: A Mother-Newborn Dyad Pilot Study.

Therapeutic drug monitoring·2026
Same journal

A Clustering-Based Grey Modeling Approach for Tacrolimus Concentration Prediction Under Sparse Therapeutic Drug Monitoring.

Therapeutic drug monitoring·2026
Same journal

Response to Panteghini "About Analytical Performance Specifications for Immunosuppressive Drug Measurements".

Therapeutic drug monitoring·2026
Same journal

Lacosamide Concentration in Various Biological Matrices (Plasma, Saliva, and Hair) Does Not Correlate with Clinical Outcomes in Patients with Epilepsy.

Therapeutic drug monitoring·2026
Same journal

Comparison of Creatinine-Based, Cystatin C-Based, and Combined Kidney Function Estimates for Vancomycin Clearance Prediction.

Therapeutic drug monitoring·2026
See all related articles

Premature blood sampling for therapeutic digoxin level monitoring is common. This practice leads to falsely elevated digoxin concentrations, potentially impacting patient management and resource utilization.

Area of Science:

  • Pharmacology
  • Clinical Chemistry
  • Health Services Research

Background:

  • Therapeutic drug monitoring (TDM) of digoxin is crucial for optimizing patient outcomes.
  • Accurate timing of blood sampling relative to drug administration is essential for reliable TDM results.
  • Previous studies suggest potential issues with TDM sample timing in clinical practice.

Purpose of the Study:

  • To audit the appropriateness of blood sampling timing for therapeutic digoxin level monitoring.
  • To assess the impact of sampling timing on measured digoxin concentrations.
  • To evaluate the clinical and statistical significance of discrepancies in sampling times.

Main Methods:

  • Audit of therapeutic digoxin level monitoring requisitions in selected hospital wards.

Related Experiment Videos

  • Definition of appropriate sampling time: ≥6 hours post-last digoxin dose.
  • Estimation of sampling time based on laboratory logging and patient treatment sheet data when not explicitly stated.

    • Main Results:

    • Nine out of 22 (41%) requisitions with detailed sampling times were deemed inappropriate.
    • Forty-five out of 150 (30%) estimated sampling times were considered inappropriate.
    • Appropriate timing yielded a mean digoxin concentration of 1.0 nM, significantly lower than the 1.6 nM observed with premature sampling (p < 0.001).

    Conclusions:

    • Premature blood sampling for digoxin level monitoring is prevalent in clinical practice.
    • Inappropriate sampling timing is associated with significantly higher measured digoxin concentrations.
    • Adherence to proper sampling protocols is vital for accurate digoxin level interpretation, reliable data, and efficient resource use.